Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Vesanoid
DRUG
2 trials
Sponsors
University of Colorado, Denver
, Centre Leon Berard
Conditions
Hypopharynx Cancer
Larynx Cancer
Melanoma
Oropharynx Cancer
Primary Head and Neck Tumor
Phase 2
Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Completed
NCT02403778
University of Colorado, Denver
Melanoma
Start: 2015-12-17
End: 2023-01-18
Updated: 2023-09-21
Phase 3
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
Recruiting
NCT06706401
Centre Leon Berard
Hypopharynx Cancer, Larynx Cancer, Oropharynx Cancer +1
Start: 2025-02-20
End: 2029-01-31
Target: 460
Updated: 2025-11-18
Related Papers
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab.
2018-08-16
151 citations